| Identification | Back Directory | [Name]
N-(2-Chloro-4-hydroxy-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide | [CAS]
910297-57-3 | [Synonyms]
BMS748730
BMS-748730
BMS 748730
4’-Hydroxy Dasatinib
Dasatinib metabolite M20
4'-HYDROXY DASATINIBDISCONTINUED
N-(2-Chloro-4-hydroxy-6-Methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-Methyl-4
N-(2-Chloro-4-hydroxy-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide
N-(2-chloro-4-hydroxy-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide | [Molecular Formula]
C22H26ClN7O3S | [MDL Number]
MFCD18252609 | [MOL File]
910297-57-3.mol | [Molecular Weight]
504 |
| Hazard Information | Back Directory | [Uses]
An oxidative metabolite of Dasatinib (M20 metabolite); used in the treatment of cancers and immune diseases. It is a COVID19-related research product. | [Uses]
As an oxidative metabolite of Dasatinib (M20 metabolite), 4'-Hydroxy Dasatinib can be used in the treatment of cancers and immune diseases.
|
|
|